TGF-β block treatment caused an increase in CD11b+/Ly6 TANs that are more lobulated and hypersegmented, more cytotoxic to tumor cells, and exhibit a more significant tumor-killing effect [39]. The gene discussed is TGFB1; the disease is neoplasm.